Immunodiagnostics Market Worth US$ 22,732.7 Mn by 2025 says Fortune Business Insights

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

The increasing number of geriatric population, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the global immunodiagnostics market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2018-2025,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2025.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/immunodiagnostics-market-100444

The immune system of a human is one of the most complex networks. Recent advancements in global immunodiagnostics market have improvised diagnosis of this complex network. A rise in infectious diseases like HIV, cancer, hepatitis, and other cardiovascular diseases is aiding expansion of the immunodiagnostics market. Furthermore, advancements in technology will stoke growth of the global immunodiagnostics market during the forecast period. The report provides an in-depth analysis of various factors that have contributed to the growth of the global immunodiagnostics market.

Oncology and Endocrinology Segment Will Witness Increasing Demand

The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.

Request Sample [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444

Asia Pacific to Remain Dominant in the Market

The global immunodiagnostics market can be geographically segmented into Latin America, North America, Asia Pacific, Middle East, Europe and Africa. Amongst these regions, the Asia Pacific market was worth US$ 3,949.1 Mn in 2017, and it is still likely to generate a comparatively high CAGR during the forecast period. As there is an increasing awareness among the masses regarding disease management, it encourages them to go for regular health check-ups and tests. This has also enhanced the global immunodiagnostics market.

Moreover, an increasing number of players in the region, rising awareness, and advancements in health care industry will drive the immunodiagnostics market in Asia Pacific. It is anticipated that China and India will exhibit high demand for immunodiagnostics in Asia Pacific. This is because of the presence of unmet medical needs in the region. The immunodiagnostics market in the Middle East and Latin America is projected to expand considerably by the end of 2025, because of the rise in infectious and cardiovascular diseases in these regions.

TABLE OF CONTENT:

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Technological Advancements

4.2 Key Industry Developments -Mergers, Acquisitions and Partnerships

4.3 Reimbursement Scenario

4.4 Key Performance Indicators for Global Immunodiagnostics Market

  1. Global Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast By Product

5.2.1 Instruments

5.2.2 Reagents and Consumables

5.3. Market Analysis, Insights and Forecast By Application

5.3.1 Oncologyand Endocrinology

5.3.2 Hepatitis and Retrovirus

5.3.3 Cardiac Markers

5.3.4 Infectious Diseases

5.3.5 Others

5.4. Market Analysis, Insights and Forecast By End User

5.4.1 Clinical Laboratories

5.4.2 Hospitals

5.4.3 Physician’s Offices

5.4.4 Others

5.5. Market Analysis, Insights and Forecast By Region

5.5.1 North America

5.5.2 Europe

5.5.3 Asia Pacific

5.5.4 Latin America

5.5.5 Middle East and Africa

More Trending Topics From Fortune Business [email protected]

Glaucoma Therapeutics Market to Value US$ 10,091 Mn by 2026, Recenft Technological Advancements to Boost Market, says Fortune Business Insights

Medical Imaging Equipment Market Forecast to Exhibit a CAGR of 4.6%

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]